Cognex Corporation
At today's price, Cognex Corporation (CGNX) is priced for today's economics sustained for ~16.0 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
At $66.15 (June 27, 2026) the price pays about 58x company-wide operating income, which the model reads as a bet that operating growth holds near its self-funding ceiling for roughly 17 years. That looks extreme until you note the denominator: trailing operating margin of 18.8% is depressed by a recently weak industrial cycle that is now turning. The recovery is well underway. Q1 2026 revenue rose 24% year over year, operating margin reached 22.3%, and adjusted EBITDA margin expanded over 1,000
Is CGNX overvalued? See what's priced in →
551 institutional managers reported holding CGNX in 13F filings for the quarter ended 2026-03-31. Together they hold about 93% of the company; the top 10 hold 43%. 104 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 6.6M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (3.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CGNX has cut its share count 5.7% over the past five years, spending $756.59M on repurchases. It pays a dividend, and has for 11 years running, raised 4 years straight; the current rate is $0.33 a share annually. Cash returned over the past three years: $146.07M in dividends and $347.94M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CGNX over the trailing three years: 2024: 3 buys totaling $327k. 13 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CGNX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-04 | -3.2% | -14.6% |
| 2023-11-01 | -0.5% | +12.2% |
| 2024-02-16 | +5.5% | +0.9% |
| 2024-05-03 | +7.0% | +8.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CGNX's latest 8-K filings: 2026-05-06 (items 2.02, 8.01, 9.01); 2026-04-30 (items 5.02, 5.07, 9.01); 2026-02-17 (items 5.02, 7.01, 9.01); 2026-02-11 (items 2.02, 8.01, 9.01); 2025-11-03 (items 4.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.